Singapore markets closed

BioNexus Gene Lab Corp. (BGLC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6096+0.0075 (+1.25%)
As of 04:00PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-109.754
-2,629
-355.966
751.571
1,094
Depreciation & amortisation
105.878
108.423
105.419
108.215
101.603
Stock-based compensation
511.74
511.74
0
-
-
Change in working capital
455.339
117.979
833.385
-862.248
102.361
Accounts receivable
1,416
650.81
538.646
579.217
411.069
Inventory
391.736
-160.387
544.108
-345.745
147.038
Other working capital
514.146
-1,451
497.651
5.999
131.059
Other non-cash items
8.877
8.877
7.794
-
-
Net cash provided by operating activities
552.569
-1,302
551.822
9.161
552.68
Cash flows from investing activities
Investments in property, plant and equipment
-38.423
-149.398
-54.171
-3.162
-421.621
Purchases of investments
-481.521
-320.733
-511.706
-515.84
-108.631
Sales/maturities of investments
-0.022
26.146
0
6.392
30.059
Net cash used for investing activities
-476.884
-382.576
-450.498
-490.574
1,320
Cash flows from financing activities
Debt repayment
-38.997
0
-34.038
-26.302
-4.947
Common stock issued
-
-
150
0
-
Dividends paid
0
0
0
-
-
Other financing activities
150
5,763
150
-1.92
-
Net cash used provided by (used for) financing activities
111.003
5,754
108.168
-28.222
-4.947
Net change in cash
-238.127
3,810
-5.055
-663.773
1,929
Cash at beginning of period
1,700
2,119
2,124
2,788
859.076
Cash at end of period
1,887
5,929
2,119
2,124
2,788
Free cash flow
Operating cash flow
552.569
-1,302
551.822
9.161
552.68
Capital expenditure
-38.423
-149.398
-54.171
-3.162
-421.621
Free cash flow
514.146
-1,451
497.651
5.999
131.059